Key Takeaways
- A new FDA draft guidance describes a seven-step, risk-based framework for assessing and demonstrating the credibility of artificial intelligence models when outputs are used to make drug regulatory decisions.
The US Food and Drug Administration wants drug sponsors to follow a seven-step framework for assessing and establishing the credibility...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?